Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
about
Neurochemical correlates of caudate atrophy in Huntington's disease.Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease.Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain.Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.Results of the citalopram to enhance cognition in Huntington disease trial.Protein oxidation in Huntington disease.Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model.Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection.Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice.Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation.Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
P2860
Q30737232-F97B524B-33C7-48FC-8D04-6BAF0F9C87CEQ34152284-30346699-4525-4FDA-B5D4-9DC275623A7BQ34524923-CDB1573E-99C5-44E3-8940-43CBF30E6702Q36931971-79EA4C89-8F9F-4A08-BEF6-EAA4DA5789AEQ37649788-DDDB280F-CBA2-4708-BA71-1AED7BC0C98BQ37999718-507BBD7E-E129-47C4-993D-9D1AEA5735AEQ39357699-CD89E9E9-600E-441C-9D16-E723C745DB11Q42055923-F58ACD1A-BF0E-480D-B5AF-CB330104B8A1Q42489395-903A850D-D70A-4032-8BF4-334FAE818B9CQ45291917-D4351960-85BE-4632-A5FF-063048126E27Q45297581-D0498645-2510-4EC0-892A-BCB7211CC3E1Q45300518-1DD71D13-C6B6-46EE-803C-1FEC6B4EACB1
P2860
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@en
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@nl
type
label
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@en
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@nl
prefLabel
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@en
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@nl
P1433
P1476
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
@en
P2093
Pearson SJ
P304
P356
10.1016/0304-3940(87)90639-2
P407
P577
1987-07-01T00:00:00Z